Screener
BioMarin Pharmaceuticals BMRN Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
FAQ
- What is BioMarin Pharmaceuticals's inventories?
- BioMarin Pharmaceuticals (BMRN) reported inventories of $1.78B in Q2 2026.
- How has BioMarin Pharmaceuticals's inventories changed year-over-year?
- BioMarin Pharmaceuticals's inventories increased by 33.0% year-over-year, from $1.34B to $1.78B.
- What is the long-term trend for BioMarin Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's inventories has grown at a 13.2% compound annual growth rate (CAGR), from $698.55M to $1.3B.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about BioMarin Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude